Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2370356
Max Phase: Preclinical
Molecular Formula: C47H75N13O10S
Molecular Weight: 1014.26
Molecule Type: Protein
Associated Items:
ID: ALA2370356
Max Phase: Preclinical
Molecular Formula: C47H75N13O10S
Molecular Weight: 1014.26
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@@H]1N(C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC)C(C)C)[C@@H](C)CC)CSC1(C)C)C(=O)O
Standard InChI: InChI=1S/C47H75N13O10S/c1-10-26(5)36(42(66)56-33(20-29-21-51-23-53-29)44(68)60-24-71-47(7,8)38(60)43(67)59-37(45(69)70)27(6)11-2)58-40(64)32(19-28-14-16-30(61)17-15-28)55-41(65)35(25(3)4)57-39(63)31(54-34(62)22-50-9)13-12-18-52-46(48)49/h14-17,21,23,25-27,31-33,35-38,50,61H,10-13,18-20,22,24H2,1-9H3,(H,51,53)(H,54,62)(H,55,65)(H,56,66)(H,57,63)(H,58,64)(H,59,67)(H,69,70)(H4,48,49,52)/t26-,27-,31-,32-,33-,35-,36-,37-,38-/m0/s1
Standard InChI Key: HVCBOEMVQREBPD-AQUQQKPWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1014.26 | Molecular Weight (Monoisotopic): 1013.5481 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Samanen J, Cash T, Narindray D, Brandeis E, Adams W, Weideman H, Yellin T, Regoli D.. (1991) An investigation of angiotensin II agonist and antagonist analogues with 5,5-dimethylthiazolidine-4-carboxylic acid and other constrained amino acids., 34 (10): [PMID:1920354] [10.1021/jm00114a012] |
Source(1):